Abstracts

474 – Optimized ACE2-Fc With Picomolar Pan-Neutralization of SARS-CoV-2 Variants, Including JN.1 and KP.2

Background Many neutralizing monoclonal antibodies capable of providing sterilizing immunity against SARS-CoV-2 have been developed and temporarily approved for emergency clinical use as prophylactics. However, the rapid evolution of SARS-CoV-2 progressively renders these treatments obsolete. Several groups have been exploring the use of ACE2-based Fc fusion proteins to obtain a pan-variant neutralizing molecule. In this…

371 – Sex Differences in Cytokine Responses and Genetic Regulation Thereof in People Living With HIV

Background Females living with HIV have improved viral control but increased immune activation compared to males. Some of these differences appear before puberty, suggesting a role of genetics, but this remains poorly understood. In this study, we assessed the effect of biological sex on circulating cytokine levels and cytokine production upon PBMC stimulation, and the…

408 – HIV-1-Specific T Cells From Post-Treatment Controllers and Noncontrollers

Background Understanding the immune response to HIV-1 in individuals maintaining long-term viral suppression after analytical treatment interruption (ATI) is crucial in the search for a functional cure. A subset of individuals, post-treatment controllers (PTCs), experience sustained virologic control following ATI, whilst non-controllers (NCs) require re-initiation of antiretroviral therapy (ART) to suppress rebounding viremia. We investigated…

404 – TCR Convergence in HIV Controllers: Insights Into Natural Viral Suppression

Background HIV controllers are rare individuals who suppress viral replication without antiretroviral therapy (ART). We hypothesized that this might partly be driven by T-cell receptor (TCR) convergence, a phenomenon where different DNA sequences encode identical amino acids. TCR convergence may indicate antigen-driven selection, reflecting a more focused immune response. This study applies a novel method…

470 – Females With HIV Favor Interferon Responses Over Inflammation Upon TLR7 Activation

Background Females have lower viral setpoints and are more likely to control HIV infection without ART than males, though the mechanisms remain unclear. The X-chromosome-encoded ssRNA receptor TLR7 may contribute to this difference as evasion of X-inactivation in females can increase TLR7 expression. TLR7 activation induces type-I Interferon (IFN) release and production of pro-inflammatory cytokines, but its…

499 – Genetic Regulation of Immune Responses to CMV in Spontaneous HIV Controllers

Background HIV controllers (HICs) spontaneously control an HIV infection and are important to understand HIV immunopathogenesis. We previously showed that HIV-control associated genetic variants in the MHC locus downregulate IL-1β and TNF-α responses to CMV pp65 in PBMCs in people living with HIV (PLHIV) (CROI 2024, abstract 319). Here, we investigated how cytokine responses are organized…